Coagulation analyzers/reagents

Active Awarded Last action

Contract number
HT940825F0005
Awardee
Awarding agency
Obligated
$133,938

Award facts

Contract value 37% obligated
  • $133,938.42 Current, with exercised options
  • $363,547.14 Potential, with all options
Completion date 36% complete
  • Current, with exercised options
  • Potential, with all options
Contracting staff
Set-aside
No set-aside
Competition
Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
Pricing
Firm Fixed Price
Place of performance
Eglin AFB, FL 32542, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Funding Only Action P00003 $76,536
Exercise an Option P00002 $0
Funding Only Action P00001 $57,402
Original award $0

About this award

The Defense Health Agency awarded a delivery order valued at $363,547.14 to Diagnostica Stago Inc. on February 1, 2025, for coagulation analyzers and reagents to support clinical laboratory operations at Eglin Air Force Base, Florida. This delivery order, which extends through October 31, 2029, is issued under the GSA Schedule 66-III for Critical Analyzers, Laboratory Equipment and Supplies and represents an open competition award with no set-aside designation. Diagnostica Stago Inc., a foreign-owned medical device manufacturer headquartered in Parsippany, New Jersey, specializes in hemostasis and thrombosis testing technologies and has maintained federal contractor status since November 2001.

This award builds upon Diagnostica Stago's established relationship with the Defense Health Agency, which currently holds multiple blanket purchase agreements with the company, including a $1.3 million BPA effective through March 27, 2030, for diagnostic supplies, reagents, and consumables. The company has demonstrated consistent success competing for federal healthcare diagnostic equipment procurement across multiple agencies, including the Department of Veterans Affairs, Navy Bureau of Medicine and Surgery, and other federal healthcare entities. Diagnostica Stago supplies specialized coagulation testing equipment, including its STA line of compact and automated hemostasis analyzers, along with associated reagents, controls, and maintenance services under various pricing models tailored to federal healthcare laboratory requirements.

Quick answers

Who was awarded contract HT940825F0005?

HT940825F0005 was awarded to Diagnostica Stago Inc. by Defense Health Agency (Department of Defense) on February 1, 2025.

How much is contract HT940825F0005 worth?

The government has obligated $133,938 on HT940825F0005. Its potential value, with all options, is $363,547.

Is contract HT940825F0005 an order under another contract?

Yes. HT940825F0005 is a delivery order under 36F79718D0351, a federal supply schedule, on Critical Analyzers, Laboratory (FSS-66-III).

Was contract HT940825F0005 competed?

The extent of competition for HT940825F0005 was full and open competition. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award